CLRB

Conviction 0HealthcareScan · Thu, Jun 25, 2026

CLRB$2.51+0.80%

ResistanceSupportVol 14Insider buy

Vol MA14 130.65K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Cellectar Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.cellectar.com ↗

Price2.51

Change+0.80%

Gap+1.20%

Rel volume0.02×

Avg volume152.5K

Avg $ vol404.04K

SMA 202.58

SMA 502.82

SMA 2003.42

Price vs 50-11.00%

Price vs 200-26.62%

MA stackbearish

50/200 cross—

Supertrenddown · 2.92

RSI (14)45

MACD hist0.02

MACD crossbull · 4d

Stoch %K / %D42 / 41

ADX (14)18

+DI / −DI22 / 18

RSI divergence—

MACD divergence—

ATR %+8.79%

ADR %7.89%

52w high7.94

52w low2.23

From 52w high-68.39%

Above 52w low+12.56%

New 52w highNo

SqueezeOff

Bollinger width40.51%

%B0.43

Donchian pos28.97%

Donchian high3.27

Donchian low2.20

AVWAP (52w high)3.76

vs AVWAP high-33.17%

AVWAP (52w low)2.51

vs AVWAP low+0.04%

OBV trendDown

Chaikin MF (20)-0.28

Today vs 20d0.02×

Avg vol (14d)130.65K

Avg vol (20d)152.5K

Avg $ vol (20d)404.04K

Market cap20.06M

RS 3m (vs SPY)-29.53%

RS 6m (vs SPY)-14.83%

RS line new highNo

Trend template0/8

Technical rank18.9

1 week+1.21%

1 month-19.03%

3 months-14.92%

6 months-12.24%

1 year-74.12%

YTD-27.67%

P/E-0.92

P/B6.01

P/S—

P/FCF-0.87

EPS-8.35

Div yield—

ROE-653.39%

ROA-195.97%

Debt/Eq0.10

Current1.90

EV/EBITDA-0.53

Gross margin—

Net margin—

Rev growth—

EPS growth51.12%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value12.04M

Revenue—

Net income-5.65M

Gross profit—

Free cash flow-23.12M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out7.99M

Employees11

ListedTue, Apr 19, 2005

Free float7.61M

Float %95.2%

Short interest258.2K

Days to cover1.1d

Short volume42.4%

Squeeze score14 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank18.9 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.02

Support2.20

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CLRB

All disclosures →

No recent disclosed trades by Congress in CLRB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CLRB · 4 buys

Insider	Side	Shares	Value	Traded	Filed
CARUSO JAMES V Chief Executive Officer · Common Stock · 2026-05-07	Buy	8.68K	$25K	2026-05-07	2026-05-11
Longcor Jarrod Chief Operating Officer · Warrants · 2026-05-07	Buy	26.04K	$260	2026-05-07	2026-05-11
Longcor Jarrod Chief Operating Officer · Common Stock · 2026-05-07	Buy	8.68K	$25K	2026-05-07	2026-05-11
CARUSO JAMES V Chief Executive Officer · Warrants · 2026-05-07	Buy	26.04K	$260	2026-05-07	2026-05-11

SEC filings

EDGAR filings in CLRB · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.